Transcatheter closure of atrial septal defect with complete aortic rim deficiency
10.12025/j.issn.1008-6358.2023.20231393
- VernacularTitle:主动脉根部缺如的房间隔缺损经导管介入治疗疗效分析
- Author:
Ming-Fei LI
1
;
Da-Wei LIN
;
Wen-Zhi PAN
;
Xiao-Chun ZHANG
;
Sha-Sha CHEN
;
Lei ZHANG
;
Da-Xin ZHOU
;
Jun-Bo GE
Author Information
1. 复旦大学附属中山医院心血管内科,上海市心血管病研究所,国家放射与治疗临床医学研究中心,上海 200032
- Keywords:
aortic rim deficiency;
atrial septal defect;
transcatheter therapy;
safety
- From:
Chinese Journal of Clinical Medicine
2023;30(6):988-992
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the safety and efficacy of interventional therapy in patients with secondary atrial septal defect(ASD)with complete aortic rim deficiency.Methods 402 patients with ASD who underwent transcatheter closure and followed up in outpatient at both 6-month and 1-year in the Department of Cardiology,Zhongshan Hospital,Fudan University from January 2018 to June 2020 were enrolled.They were divided into complete aortic rim deficiency group and normal aortic rim group.The clinical features,interventional parameters,and complications were compared between the two groups.Echocardiographic were used to evaluate the outcome.Results The occluder size was larger in the aortic rim deficiency group([26.4±6.9]mm,n=128)than that in normal aortic rim group([23.4±7.7]mm,P<0.001;n=274).Both groups exhibited no major postoperative complications,and significant improvements were observed in right heart remodeling following the operation,including pulmonary artery pressure decreasing,the diameters of the right atrium and right ventricle reducing,and the degree of tricuspid regurgitation reducing(P<0.001).There was no significant change in left ventricular ejection fraction in all patients.Conclusion Transcatheter closure of ASD with complete aortic rim deficiency is safe and feasible.